Evidence map›Paper›PMID 26560699›Full record

SynthesisBMC medicine2015

Opening clinical trial data: are the voluntary data-sharing portals enough?

Nophar Geifman, Jennifer Bollyky, Sanchita Bhattacharya, Atul J Butte

Abstract readMeta-Analysis
In one paragraph

Synthesis in BMC medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. A method for generating synthetic longitudinal health data.BMC medical research methodology · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Leveraging Big Data to Transform Drug Discovery.Methods in molecular biology (Clifton, N.J.) · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. FHIRChain: Applying Blockchain to Securely and Scalably Share Clinical Data.Computational and structural biotechnology journal · 2018
    Article
  16. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the editors' network.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2017
    Article
  17. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors : Implications for the Editors' Network.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2017
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nophar GeifmanInstitute for Computational Health Sciences, University of California San Francisco, Mission Hall, 550 16th Street, 4th Floor, San Francisco, CA, 94158-2549, USA.
Jennifer BollykySean N. Parker Center for Allergy Research, Department of Pediatrics, Division of Allergy, Immunology & Rheumatology, Stanford University School of Medicine, Stanford, CA, USA.
Sanchita BhattacharyaInstitute for Computational Health Sciences, University of California San Francisco, Mission Hall, 550 16th Street, 4th Floor, San Francisco, CA, 94158-2549, USA.
Atul J ButteInstitute for Computational Health Sciences, University of California San Francisco, Mission Hall, 550 16th Street, 4th Floor, San Francisco, CA, 94158-2549, USA. atul.butte@ucsf.edu.

Funding

NIAID NIH HHS HHSN272201200028CPHS HHS HHSN272201200028C
6 · The paper itself

Abstract

Data generated by the numerous clinical trials conducted annually worldwide have the potential to be extremely beneficial to the scientific and patient communities. This potential is well recognized and efforts are being made to encourage the release of raw patient-level data from these trials to the public. The issue of sharing clinical trial data has recently gained attention, with many agreeing that this type of data should be made available for research in a timely manner. The availability of clinical trial data is most important for study reproducibility, meta-analyses, and improvement of study design. There is much discussion in the community over key data sharing issues, including the risks this practice holds. However, one aspect that remains to be adequately addressed is that of the accessibility, quality, and usability of the data being shared. Herein, experiences with the two current major platforms used to store and disseminate clinical trial data are described, discussing the issues encountered and suggesting possible solutions.

Indexed as

Data Interpretation, StatisticalClinical Trials as TopicHumansResearch Design

Identifiers

PMID26560699
PMCPMC4642633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.